Shared brain vulnerabilities open the way for nonsubstance addictions: Carving addiction at a new joint

Annals of the New York Academy of Sciences

Volumn 1187, Issue , 2010, Pages 294-315

  Frascella, Joseph ^a   Potenza, Marc N ^b   Brown, Lucy L ^c   Childress, Anna Rose ^d,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Affairs Medical Center   (United States)

Author keywords

Brain imaging; DSM V; Nonsubstance addiction; Nosology

Indexed keywords

ALCOHOLISM; COCAINE DEPENDENCE; DISEASE PREDISPOSITION; DRUG DEPENDENCE; EMOTIONAL ATTACHMENT; HUMAN; LIBIDO; LOVE; MOTHER CHILD RELATION; NEUROIMAGING; OBESITY; PATHOLOGICAL GAMBLING; REVIEW; REWARD; SEXUAL BEHAVIOR; WITHDRAWAL SYNDROME;

EID: 77949280009     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05420.x     Document Type: Review

References (261)

1. Jowett, B. 1937. The Dialogues of Plato: Phaedrus. Random House. New York.
2. Saunders, J.B.&M.A. Schuckit. 2006. The development of a Research agenda for substance use disorders diagnosis in the Diagnostic and StatisticalManual ofMental Disorders, fifth edition (DSM-V). Addiction 101(Suppl 1): 1-5.
3. American Psychiatric Association Committee on Nomenclature and Statistics. 1952. Diagnostic and Statistical Manual of Mental Disorders, 1st ed. American Psychiatric AssociationMentalHospital Service.Washington, DC.
4. American Psychiatric Association Committee on Nomenclature and Statistics. 1968. Diagnostic and Statistical Manual of Mental Disorders, 2nd ed. American Psychiatric Association.Washington, DC.
5. American Psychiatric Association Committee on Nomenclature and Statistics. 1980. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. American Psychiatric Association.Washington, DC.
6. Weintraub, D. et al. 2006. Association of dopamine agonist usewith impulse control disorders in Parkinson disease. Arch. Neurol. 63: 969-973.
7. Weintraub, D. et al. 2009. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov. Disord. 24: 1461-1467.
8. Potenza, M.N. 2006. Should addictive disorders include non-substance-related conditions? Addiction 101(Suppl 1): 142-151.
9. Volkow, N.D. & R.A. Wise. 2005. How can drug addiction help us understand obesity? Nat. Neurosci. 8: 555-560.
10. Volkow, N.D. & C.P. O'Brien. 2007. Issues for DSM-V: should obesity be included as a brain disorder? Am. J. Psychiatry 164: 708-710.
11. Wang, G.J. et al. 2004. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept Rev.iew. J. Addict. Dis. 23: 39-53.
12. Gosnell, B.A. & A.S. Levine. 2009. Reward systems and food intake: role of opioids. Int. J. Obes. (Lond.) 33(Suppl 2): S54-58.
13. Kelley, A.E. et al. 2002. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 76: 365-377.
14. Drewnowski, A. et al. 1992. Taste Responses and p for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51: 371-379.
15. Potenza, M. 2001. Pathological gambling: a present problem from the past. Psychiatr. Times www.psychiatrictimes.com/srpg.html (Sept. 2001 online exclusive) (accessed November 1, 2001).
16. American Psychiatric Association Committee on Nomenclature and Statistics. 2000. Diagnostic and Statistical Manual of Mental Disorders (4th ed., text Rev.ision). American Psychiatric Association. Washington, DC.
17. Tavares, H. et al. 2005. Comparison of craving between pathological gamblers and alcoholics. Alcohol. Clin. Exp. Res. 29: 1427-1431.
18. Grant, J.E. et al. 2008. Predicting Response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 200: 521-527.
19. Brewer, J.A., J.E. Grant & M.N. Potenza. 2008. The treatment of pathological gambling. Addict. Disorders Treatment 7: 1-14.
20. Cunningham-Williams, R.M. et al. 1998. Taking chances: problem gamblers and mental health disorders-Results from the St. Louis Epidemiologic Catchment Area Study. Am. J. Public Health 88: 1093-1096.
21. Petry, N.M., F.S. Stinson & B.F. Grant. 2005. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 66: 564-574.
22. Wagner, F. & J.C. Anthony. 2002. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26: 479-488.
23. Potenza,M.N. 2006. Should addictive disorders include non-substance-related conditions? Addiction 101(s1): 142-151.
24. Lynch, W., P.K. Maciejewski & M.N. Potenza. 2004. Psychiatric correlates of gambling in adolescents and young adults grouped by age of gambling onset. Arch. Gen. Psychiatry 61: 1116-1122.
25. Kessler, R.C. et al. 2008. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol. Med. 38: 1351-1360.
26. Potenza, M.N. et al. 2001. Gender-related differences in the charactaristics of problem gamblers using a gambling helpline. Am. J. Psychiatry 158: 1500-1505.
27. Tavares, H., M.L. Zilberman, F.J. Beites & V. Gentil. 2001. Gender differences in gambling prog ression. J. Gambling Stud. 17: 151-160.
28. Piazza, N., J.L. Vrbka & R.D. Yaeger. 1989. Telescoping of alcoholism in women alcoholics. Int. J. Addict. 24: 19-28.
29. Tsuang, M., M.J. Lyons, J.M. Meyer, et al. 1998. Cooccurrence of abuse of different drugs in men. Arch. Gen. Psychiatry 55: 967-972.
30. Eisen, S.A. et al. 1998. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 93: 1375-1384.
31. Kendler, K. et al. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 60: 929-937.
32. Slutske,W.S. et al. 2000. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch. Gen. Psychiatry 57: 666-674.
33. Slutske,W.S. et al. 2001. A twin study of the Association between pathological gambling and anti social personality disorder. J. Abnorm. Psychology 110: 297-308.
34. Kreek, M.J. et al. 2005. Genetic influences on impulsivity, risk-taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 8: 1450-1457.
35. Brewer, J.A. & M.N. Potenza. 2008. The neuro biology and genetics of impulse control disorders: relationships to drug addictions. Biochem. Pharmacol. 75: 63-75.
36. Comings, D.E. 1998. The molecular genetics of pathological gambling. CNS Spectr. 3: 20-37.
37. da Silva Lobo, D.S. et al. 2007. Dopamine genes and pathological gambling in discordant sib-pairs. J. Gambling Stud. 23: 421-433.
38. Blaszczynski, A., Z. Steel & N. McConaghy. 1997. Impulsivity in pathological gambling: the anti social impulsivist. Addiction 92: 75-87.
39. Petry, N.M. 2001. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend. 63: 29-38.
40. Petry, N. 2001. Pathological gamblers,with andwithout substance use disorders, discount delayed rewards at high rates. J. Abnorm. Psychol. 110: 482-487.
41. Potenza, M.N. et al. 2003. An fMRI Stroop task study of ventro medial prefrontal cortical function in pathological gamblers. Am. J. Psychiatry 160: 1990-1994.
42. Cavedini, P. et al. 2002. Frontal lobe dysfunction in pathological gambling. Biol. Psychiatry 51: 334-341.
43. Bechara, A. 2003. Risky business: emotion, decisionmaking, and addiction. J. Gambling Stud. 19: 23-51.
44. Goudriaan, A.E. et al. 2006. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 101: 534-547.
45. Lawrence, A.J. et al. 2009. Problem gamblers share deficits in impulsive decision-making with alcohol dependent individuals. Addiction 104: 1006-1015.
46. Crews, F.T. et al. 2005. Alcoholic neuro biology: changes in dependence and recovery. Alcohol Clin. Exp. Res. 29: 1504-1513.
47. Beveridge, T.J.R. et al. 2008. Parallel studies of cocainerelated neural and cognitive impairment in humans and monkeys. Phil. Trans. Royal Soc. B 363: 3257-3266.
48. Nasrallah, N.A., T.W.H. Yang & I.L. Bernstein. 2009. Risky decision making following adolescent alcohol exposure. InWinter Conference on Brain Research. Copper Mountain, CO.
49. Reuter, J. et al. 2005. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat. Neurosci. 8: 147-148.
50. Wrase, J. et al. 2007. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 35: 787-794.
51. Pearlson, G.D. et al. 2007. Abnormal fMRI Activation of Reward Circuitry in Current versus Former Cocaine Abusers. Abstract available from the author, Godfrey Pearlson: godfrey.pearlson@yale.edu.
52. Knutson,B.,G.W. Fong, C.M.Adams, et al. 2001. Dis sociation of reward anticipation and outcome with eventrelated fMRI. Neuroreport 12: 3683-3687.
53. Knutson, B., G.W. Fong, S.M. Bennett, et al. 2003. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterizationwith rapid eventrelated fMRI. Neuroimage 18: 263-272.
54. Potenza,M.N. et al. 2003. Gambling urges in pathological gamblers: an fMRI study. Arch. Gen. Psychiatry 60: 828-836.
55. Tanabe, J. et al. 2007. Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum. Brain Mapp. 28: 1276-1286.
56. Rogers, R. 2009. The neural substrates of some of the behavioral and cognitive biases observed in problemgambling. In Winter Conference on Brain Research. Copper Mountain, CO.
57. Campbell-Meiklejohn, D.K. et al. 2008. Knowing when to stop: the brain mechanisms of chasing losses. Biol. Psychiatry 63: 293-300.
58. Petry, N. 2003. Patterns and correlates of gamblers anonymous attendance in pathological gamblers seeking professional treatment. Addict. Behav. 28: 1049-1062.
59. Petry, N.M. 2005. Gamblers anonymous and cognitivebehavioral therapies for pathological gamblers. J. Gambling Stud. 21: 27-33.
60. Petry, N.M. et al. 2006. Cognitive-behavioral therapy for pathological gamblers. J. Consult. Clin. Psychol. 74: 555-567.
61. Petry, N.M. et al. 2008. A randomized trial of brief interventions for problem and pathological gamblers. J. Consult. Clin. Psychol. 76: 318-328.
62. Miller, W. 1995. Motivational enhancement therapy with drug abusers [cited 2005 January 15]. http:// motivationalinterview.org/clinical/ metdrugabuse. pdf (accessed November 2009).
63. Hodgins, D., S.R. Currie & N. el-Guebaly. 2001. Motivational enhancement and self-help treatments for problem gambling. J. Clin. Consult. Psychol. 69: 50-57.
64. Pettinati, H., D. Oslin & K. Decker. 2000. Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence. CNS Spectr. 5: 33-46.
65. Grant, J., S.W. Kim, M.N. Potenza, et al. 2003. Paroxetine treatment of pathological gambling: amulti-center randomized controlled trial. Int. Clin. Psychopharmacol. 18: 243-249.
66. Kalivas, P.W. & N.D. Volkow. 2005. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162: 1403-1413.
67. Hedley, A.A. et al. 2004. prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291: 2847-2850.
68. Ogden, C.L., M.D. Carroll & K.M. Flegal. 2008. High body mass index for age among US children and adolescents, 2003-2006. JAMA 299: 2401-2405.
69. Haslam, D.W. & W.P.T. James. 2005. Obesity. Lancet 366: 1197-1209.
70. Yach, D., D. Stuckler & K.D. Brownell. 2006. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat. Med. 12: 62-66.
71. Gearhardt, A.N., W.R. Corbin & K.D. Brownell. 2009. Food addiction: an examination of the diagnostic criteria for dependence. J. Addict. Med. 3: 1-6.
72. Cocores, J.A. & M.S. Gold. 2009. The Salted Food AddictionHypothesismay explain overeating and the obesity epidemic. Med. Hypotheses 73: 892-899.
73. Ifland, J.R. et al. 2009. Refined food addiction: a classic substance use disorder. Medical Hypotheses 72: 518-526.
74. Devlin,M.J. 2007. Is there a place for obesity in DSM-V? Int. J. Eating Disord. 40(S3): S83-S88.
75. Corwin, R.L. & P.S. Grigson. 2009. Symposium overview-food addiction: fact or fiction? J. Nutr. 139: 617-619.
76. Dagher, A. 2009. The neuro biology of appetite: hunger as addiction. Int. J. Obes. 33(S2): S30-S33.
77. Gold, M.S. et al. 2009. Food addiction? J. Addict. Med. 3: 42-44.
78. Rolls, E.T. 2007. Understanding the mechanisms of food intake and obesity. Obes. Rev. 8(s1): 67-72.
79. Kelley, A.E. & K.C. Berridge. 2002. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22: 3306-3311.
80. O'Doherty, J.P. 2004. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr. Opin. NeuroBiol. 14: 769-776.
81. Saper, C.B., T.C. Chou & J.K. Elmquist. 2002. The need to feed: homeostatic and hedonic control of eating. Neuron 36: 199-211.
82. Valentin,V.V., A. Dickinson&J.P. O'Doherty. 2007. Determining the neural substrates of goal-directed learning in the human brain. J. Neurosci. 27: 4019-4026.
83. O'Doherty, J. 2007. Lights, camembert, action! The role of human orbitofrontal cortex in encoding stimuli, rewards, and choices. Ann. N. Y. Acad. Sci. 1121: 254-272.
84. Roberts, D.C., M.E. Corcoran & H.C. Fibiger. 1977. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6: 615-620.
85. Di Chiara, G. & A. Imperato. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
86. Bradberry, C.W. 2000. Acute and chronic dopamine dynamics in a nonhumanprimatemodel of recreational cocaine use. J. Neurosci. 20: 7109-7115.
87. Carboni, E. et al. 1989. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freelymoving rats. Neuroscience 28: 653-661.
88. DiChiara, G. et al. 2004.Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1): 227-241.
89. McCullough, L.D. & J.D. Salamone. 1992. Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study. Brain Res. 592: 29-36.
90. Pontieri, F.E., G. Tanda & G. Di Chiara. 1995. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 92: 12304-12308.
91. Ritz, M.C. et al. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
92. Ritz, M.C. et al. 1988. Cocaine self-administration appears to be Mediated by dopamine uptake inhibition. Prog. Neuropsychopharmacol. Biol. Psychiatry 12: 233-239.
93. Spanagel,R.&F.Weiss. 1999. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22: 521-527.
94. Wise, R.A. 2004. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5: 483-494.
95. Wise, R.A. & M.A. Bozarth. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492.
96. Hernandez, L. & B.G. Hoebel. 1988. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol. Behav. 44: 599-606.
97. Hernandez, L. & B.G. Hoebel. 1988. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42: 1705-1712. (Pubitemid 18107374)
98. Hoebel, B.G. et al. 1989. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior theoretical and clinical implications. Ann. N. Y. Acad. Sci. 575: 171-193.
99. McCullough, L.D. & J.D. Salamone. 1992. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577: 1-9.
100. Radhakishun, F.S., J.M. van Ree & B.H. Westerlink. 1988. Scheduled eating increases dopamine release in thenucleus accumbens of food-deprived rats as assessed with on-line brain dialysis. Neurosci. Lett. 85: 351-356.
101. Yoshida, M. et al. 1992. Eating and drinking cause increased dopamine release in the nucleus accumbens and ventral tegmental area in the rat: measurement by in vivo microdialysis. Neurosci. Lett. 139: 73-76.
102. Westerlink, B.H., A. Teisman & J.B. de Vries. 1994. Increase in dopamine release fromthe nucleus accumbens in Response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 349: 230-235.
103. Martel, P. & M. Fantino. 1996. Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study. Pharmacol. Biochem. Behav. 55: 297-302. (Pubitemid 26414114)
104. Martel, P. & M. Fantino. 1996. Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol. Biochem. Behav. 53: 221-226. (Pubitemid 26117745)
105. Kringelbach, M.L. et al. 2003. Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb. Cortex 13: 1064-1071.
106. Berridge, K.C. 1996. Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 20: 1-25.
107. Berthoud,H.-R. 2002.Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 26: 393-428.
108. Norgren, R.,A.Hajnal&S.S.Mungarndee. 2006.Gustatory reward and the nucleus accumbens. Physiol. Behav. 89: 531-535.
109. Kringelbach, M.L. 2005. The human orbitofrontal cortex: linking reward to hedonic experience. Nat. Rev. Neurosci. 6: 691-702.
110. Small, D.M., M. Jones-Gotman & A. Dagher. 2003. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19: 1709-1715.
111. Small,D.M. et al. 2001.Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 124: 1720-1733.
112. Berridge, K.C.&M.L.Kringelbach. 2008.Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199: 457-480.
113. Rolls, E.T. 2007. Sensory processing in the brain related to the control of food intake. Proc.Nutr. Soc. 66: 96-112.
114. De Vries, T.J. & A.N.M. Schoffelmeer. 2005. Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol. Sci. 26: 420-426.
115. Fattore, L., P. Fadda & W. Fratta. 2007. Endocannabinoid regulation of relapsemechanisms. Pharmacol. Res. 56: 418-427.
116. Maldonado, R., O. Valverde & F. Berrendero. 2006. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29: 225-232.
117. Onaivi, E.S. 2008. An endocannabinoid hypothesis of drug reward and drug addiction. Ann. N. Y. Acad. Sci. 1139: 412-421.
118. Parolaro, D., D. Vigano & T. Rubino. 2005. Endocannabinoids and drug dependence. Curr. Drug Targets CNS Neurol. Disord. 4: 643-655.
119. Solinas, M., S.R. Goldberg & D. Piomelli. 2008. The endocannabinoid system in brain reward processes. Br. J. Pharmacol. 154: 369-383.
120. Solinas, M., S. Yasar & S.R. Goldberg. 2007. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol. Res. 56: 393-405.
121. Yamamoto, T., K. Anggadiredja & T. Hiranita. 2004. New perspectives in the studies on endocannabinoid and cannabis: a role for the endocannabinoidarachidonic acid pathway in drug reward and longlasting relapse to drug taking. J. Pharmacol. Sci. 96: 382-388.
122. Van Ree, J.M., M.A.F.M. Gerrits & L.J.M.J. Vanderschuren. 1999. Opioids, reward and addiction: an encounter of Biology, psychology, andMedicine. Pharmacol. Rev. 51: 341-396.
123. Van Ree, J.M. et al. 2000. Endogenous opioids and reward. Eur. J. Pharmacol. 405: 89-101.
124. Shinohara, Y. et al. 2009. Cannabinoid in the nucleus accumbens enhances the intake of palatable solution. Neuroreport 20: 1382-1385. DOI: 10.1097/WNR.0b013e3283318010.
125. Cota, D. et al. 2003. Endogenous cannabinoid system as amodulator of food intake. Int. J. Obes. Relat.Metab. Disord. 27: 289-301.
126. Tanda, G. & S.R. Goldberg. 2003. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a Rev.iew of recent preclinical data. Psychopharmacology 169: 115-134.
127. Levine,A.S.&C.J. Billington. 2004. Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol. Behav. 82: 57-61.
128. Cota, D. et al. 2006. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res. Rev. 51: 85-107.
129. Jesudason, D. & G. Wittert. 2008. Endocannabinoid system in food intake and metabolic regulation. Curr. Opin. Lipidol. 19: 344-348.
130. Wassum,K.M. et al. 2009. Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc. Natl. Acad. Sci. USA 106: 12512-12517.
131. Volkow, N.D. et al. 1999. Reinforcing effects of psychostimulants in humans are as sociated with increases in brain dopamine and occupancy of D2 receptors. J. Pharmacol. Exp. Ther. 291: 409-415.
132. Volkow, N.D. et al. 1999. Prediction of reinforcing Responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 156: 1440-1443.
133. Volkow, N.D. et al. 2002. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44: 175-180.
134. Salamone, J.D., K. Mahan & S. Rogers. 1993. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol. Biochem. Behav. 44: 605-610.
135. O'Doherty, J. et al. 2000. Sensory-specific satietyrelated olfactory activation of the human orbitofrontal cortex. Neuroreport 11: 893-897. (Pubitemid 30173944)
136. Rolls, E.T. 2006. Brain mechanisms underlying flavor and appetite. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361: 1123-1136.
137. Pelchat, M.L. et al. 2004. Images of desire: food-craving activation during fMRI. Neuroimage 23: 1486-1493.
138. Rolls, E.T.&C.McCabe. 2007. Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur. J. Neurosci. 26: 1067-1076.
139. McClernon, F.J. et al. 2009. 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum. Psychopharmacology 204: 25-35.
140. Childress, A.R. et al. 1999. Limbic activation during cue-induced cocaine craving.Am. J. Psychiatry 156: 11-18.
141. Kilts, C.D. et al. 2001. Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 58: 334-341.
142. Franklin, T.R. et al. 2007. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 32: 2301-2309.
143. Filbey, F.M. et al. 2009.Marijuana craving in the brain. Proc. Natl. Acad. Sci. USA 106: 13016-13021.
144. Garavan, H. et al. 2000. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am. J. Psychiatry 157: 1789-1798.
145. Maas, L.C. et al. 1998. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am. J. Psychiatry 155: 124-126.
146. McBride, D. et al. 2006. Effects of expectancy and abstinence on the neural Response to smoking cues in cigarette smokers: an fMRI study.Neuropsychopharmacology 31: 2728-2738.
147. Wang, Z.F. et al. 2007. Neural substrates of abstinenceinduced cigarette cravings in chronic smokers. J. Neurosci. 27: 14035-14040.
148. Bonson, K.R. et al. 2002. Neural systems and cueinduced cocaine craving.Neuropsychopharmacology 26: 376-386.
149. Grant, S. et al. 1996. Activation of memory circuits during cue-elicited cocaine craving. Proc. Natl. Acad. Sci. USA 93: 12040-12045.
150. Stice, E. et al. 2008. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J. Abnorm. Psychol. 117: 924-935.
151. Stice, E. et al. 2008. Relation between obesity and blunted striatal Response to food is moderated by TaqIA A1 allele. Science 322: 449-452.
152. Epstein, L.H. et al. 2007. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav. Neurosci. 121: 877-886.
153. Klein, T.A. et al. 2007. Genetically determined differences in learning from errors. Science 318: 1642-1645.
154. Blum, K. et al. 2000. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs 32(Suppl i-iv): 1-112.
155. Young, R.M. et al. 2004. Advances in molecular genetics and the prevention and treatment of substance misuse: implications of Association studies of theA1 allele of the D2 dopamine receptor gene. Addict. Behav. 29: 1275-1294.
156. Najafabadi, M.S. et al. 2005. Association between the DRD2 A1 allele and opium addiction in the Iranian population.Am. J.Med. Genet.BNeuropsychiatr. Genet. 134B: 39-41.
157. Han, D.H. et al. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr. Psychiatry 49: 387-392.
158. Ito, R. et al. 2002. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-as sociated cue. J. Neurosci. 22: 6247-6253.
159. Everitt, B.J.&T.W. Robbins. 2005.Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8: 1481-1489.
160. Koob, G.F. & N.D. Volkow. 2010. Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
161. Rothemund, Y. et al. 2007. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage 37: 410-421.
162. Stoeckel, L.E. et al. 2008. Widespread reward-system activation in obese women in Response to pictures of high-calorie foods. Neuroimage 41: 636-647.
163. Stice, E. et al. 2009. Relation of obesity to consummatory and anticipatory food reward. Physiol. Behav. 97: 551-560.
164. Wang, G.-J. et al. 2002. Enhanced Res.ting activity of the oral somatosensory cortex in obese subjects. Neuroreport 13: 1151-1155.
165. Stoeckel, L.E. et al. 2009. Effective connectivity of a reward network in obese women. Brain Res. Bull. 79: 388-395.
166. Ma, N. et al. 2010. Addiction related alteration in resting-state brain connectivity. Neuroimage 49: 738-744.
167. Del Parigi, A. et al. 2002. Neuroimaging and obesity: mapping the brain Responses to hunger and satiation in humans using positron emission tomography. Ann. N. Y. Acad. Sci. 967: 389-397.
168. Gautier, J.F. et al. 2000. Differential brain Responses to satiation in obese and lean men. Diabetes 49: 838-846.
169. Gautier, J.-F. et al. 2001. Effect of satiation on brain activity in obese and lean women. Obesity 9: 676-684.
170. Volkow, N.D. et al. 1993. Decreased dopamine D2 receptor availability is as sociated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-177.
171. Volkow, N.D. et al. 1990. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am. J. Psychiatry 147: 719-724.
172. Volkow, N.D. et al. 1997. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-836.
173. Chang, L. et al. 2007. Structural and metabolic brain changes in the striatum as sociated with methamphetamine abuse. Addiction 102(Suppl 1): 16-32.
174. Volkow, N.D. et al. 2001. Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158: 2015-2021.
175. Hietala, J. et al. 1994. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116: 285-290.
176. Volkow, N.D. et al. 1996. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin. Exp. Res. 20: 1594-1598.
177. Volkow, N.D. et al. 2002. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res. 116: 163-172.
178. Fehr,C. et al. 2008.Association of lowstriatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am. J. Psychiatry 165: 507-514.
179. Wang, G.-J. et al. 1997. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174-182.
180. Malison, R.T. et al. 1998. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I]ß-CIT SPECT. Am. J. Psychiatry 155: 832-834.
181. McCann, U.D. et al. 1998. Reduced striatal dopamine transporterdensity in abstinentmethamphetamine and methcathinone users: evidence frompositron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18: 8417-8422.
182. Sekine, Y. et al. 2001. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 158: 1206-1214.
183. Laine, T.P. et al. 1999. Dopamine transporters increase in human brain after alcohol withdrawal. Mol. Psychiatry 4: 189-191.
184. Yang, Y.K. et al. 2008. Decreased dopamine transporter availability in male smokers-A dual isotope SPECT study. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 274-279.
185. Volkow, N.D. et al. 2008. Low dopamine striatal D2 receptors are as sociated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42: 1537-1543.
186. Volkow, N.D. et al. 2007. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J. Neurosci. 27: 12700-12706.
187. Volkow, N.D. et al. 2008. Inverse Association between BMI and prefrontalmetabolic activity in healthy adults. Obesity 17: 60-65.
188. Elias, M.F. et al. 2003. Lower cognitive function in the presence of obesity and hypertension: the Framingham Heart Study. Int. J.Obes. Relat. Metab. Disord. 27: 260-268.
189. Elias, M.F. et al. 2005. Obesity, diabetes and cognitive deficit: the Framingham Heart Study. NeuroBiol. Aging 26(1, Suppl 1): 11-16.
190. Gunstad, J. et al. 2006. Obesity is as sociated with memory deficits in young and middle-aged adults. Eat Weight Disord. 11: e15-19.
191. Gunstad, J. et al. 2007. Elevated body mass index is as sociated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 48: 57-61.
192. Cserj́esi, R. et al. 2009. Altered executive function in obesity. Exploration of the role of affective states on cognitive abilities. Appetite 52: 535-539.
193. Gunstad, J. et al. 2008. Body mass index and neuropsychological function in healthy children and adolescents. Appetite 50: 246-251.
194. Pannacciulli, N. et al. 2006. Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 31: 1419-1425.
195. Taki, Y. et al. 2008. Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity 16: 119-124.
196. Gunstad, J. et al. 2008. Relationship between body mass index and brain volume in healthy adults. Int. J. Neurosci. 118: 1582-1593.
197. Liu, X. et al. 1998. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology 18: 243-252.
198. Franklin, T.R. et al. 2002. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 51: 134-142.
199. Fein, G., V. Di Sclafani & D.J. Meyerhoff. 2002. Prefrontal cortical volume reduction as sociated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Dependence 68: 87-93.
200. Matochik, J.A. et al. 2003. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 19: 1095-1102.
201. Tanabe, J. et al. 2009. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol. Psychiatry 65: 160-164.
202. Sim, M.E. et al. 2007. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects.Neuropsychopharmacology 32: 2229-2237.
203. Lyoo, I. et al. 2006. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology 184: 139-144.
204. Childress, A.R. et al. 1999. Limbic activation during cue-induced cocaine craving.Am. J. Psychiatry 156: 11-18.
205. Kelley,A.E. 2004.Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44: 161-179.
206. Argilli, E. et al. 2008. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 28: 9092-9100.
207. Wanat, M.J. et al. 2008. Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure. Biol. Psychiatry 65: 646-653.
208. Mayfield, R.D., R.A. Harris & M.A. Schuckit. 2008. Genetic factors influencing alcohol dependence. Br. J. Pharmacol. 154: 275-287.
209. Schuckit,M.A. 2009. An overview of genetic influences in alcoholism. J. Subst. Abuse Treat. 36: S5-14.
210. Sinha, R. 2008. Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 1141: 105-130.
211. Archer, J.S. et al. 2006. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause 13: 528-537.
212. Carnes, P.J. 2000. Sexual addiction and compulsion: recognition, treatment, and recovery. CNS Spectr. 5: 63-72.
213. Delmonico, D.L. & P.J. Carnes. 1999. Virtual sex addiction: when cybersex becomes the drug of choice. Cyberpsychol. Behav. 2: 457-463.
214. Arnow, B.A. et al. 2002. Brain activation and sexual arousal in healthy, heterosexual males. Brain 125(Pt 5): 1014-1023.
215. Georgiadis, J.R. et al. 2006. Regional cerebral blood flow changes as sociated with clitorally induced orgasm in healthy women. Eur. J. Neurosci. 24: 3305-3316.
216. Hamann, S. et al. 2004.Men andwomen differ in amygdala Response to visual sexual stimuli. Nat. Neurosci. 7: 411-416.
217. Volkow, N.D. et al. 2009. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl 1): 3-8.
218. Volkow, N.D. et al. 2007. Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications. Arch. Neurol. 64: 1575-1579.
219. Knutson, B. et al. 2005. Distributed neural representation of expected value. J. Neurosci. 25: 4806-4812.
220. Kufahl, P.R. et al. 2005. Neural Responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 28: 904-914.
221. Breiter, H.C. et al. 1997. Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591-611.
222. Ortigue, S. et al. 2007. The neural basis of love as a subliminal prime: an event-related functional magnetic resonance imaging study. J. Cogn. Neurosci. 19: 1218-1230.
223. Agmo, A. & M. Gomez. 1993. Sexual reinforcement is blocked by infusion of naloxone into the Medial preoptic area. Behav. Neurosci. 107: 812-818.
224. Paredes, R.G. 2008. Evaluating the neuro biology of sexual reward. Ilar. J. 50: 15-27.
225. Etgen, A.M.,M.A.Ansonoff&A. Quesada. 2001.Mechanisms of ovarian steroid regulation of norepinephrine receptor-Mediated signal transduction in the hypothalamus: implications for female reproductive physiology. Horm. Behav. 40: 169-177.
226. Gonzalez-Flores, O. et al. 2007. Facilitation of estrous behavior by vaginal cervical stimulation in female rats involves alpha1-adrenergic receptor activation of the nitric oxide pathway. Behav. Brain Res. 176: 237-243.
227. Wood, R.I. 2004. Reinforcing aspects of androgens. Physiol. Behav. 83: 279-289.
228. Fisher, H. 1998. Lust, attraction and attachment in mammalian reproduction. Hum. Nat. 9: 23-52.
229. Fisher, H.E., A. Aron & L.L. Brown. 2006. Romantic love: a mammalian brain systemfor mate choice. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361: 2173-2186.
230. Aron, A. et al. 2005. Reward, motivation, and emotion systems as sociated with early-stage intense romantic love. J. Neurophysiol. 94: 327-337.
231. Fisher, H., A. Aron & L.L. Brown. 2005. Romantic love: an fMRI study of a neural mechanism for mate choice. J. Comp. Neurol. 493: 58-62.
232. Fisher, H. et al. 2005.Motivation and emotion systems as sociated with romantic love following rejection: an FMRI study. In Society for Neuroscience. Society for Neuroscience San Diego.
233. Acevedo, B. et al. 2008. Neural correlates of longterm pair-bonding in a sample of intensely in-love humans. Program No. 297.10; Abstract No. TT28.
234. - 2008 Neuroscience Meeting Planner.Washington, DC: Society for Neuroscience, 2008. http://www.sfn.org/ index.aspx?pagename=abstracts ampublications.
235. Lim, M.M., A.Z. Murphy & L.J. Young. 2004. Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster). J. Comp. Neurol. 468: 555-570.
236. Liu,Y.& Z.X.Wang. 2003.Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 121: 537-544.
237. Bowlby, J. 1973. Attachment and Loss: Separation: Anxiety and Anger, Vol.2. Basic Books.New York.
238. Harlow, H.F. & R.R. Zimmermann. 1959. Affectional Responses in the infant monkey; orphaned baby monkeys develop a strong and persistent attachment to inanimate surrogate mothers. Science 130: 421-432.
239. Strathearn, L. et al. 2008. What's in a smile? Maternal brain Responses to infant facial cues. Pediatrics 122: 40-51.
240. Flores, P.J. 2001. Addiction as an attachment disorder: implications for group therapy. Int. J.Group Psychother. 51: 63-81.
241. Flores, P.J. 2004. Addiction as an Attachment Disorder. Jason Aronson. New York, p. 345.
242. Kraemer, G.W. 1985. Effects of differences in early social experience on primate neurobiological-behavioral development. In The Psycho biology of Attachment and Separation. M. Reite & T. Fields, Eds: 135-157. Academic Press. New York.
243. Martikainen, P.&T. Valkonen. 1996.Mortality after the death of a spouse: rates and causes of death in a large Finnish cohort. Am. J. Public Health 86: 1087-1093.
244. Risinger, R.C. et al. 2005. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26: 1097-1108.
245. Childress, A.R. et al. 2008. Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoSONE 3: e1506.
246. O'Brien, C. & J.W. Cornish. 2006. Naltrexone for probationers and parolees. J. Subst. Abuse Treat. 31: 107-111.
247. Oslin, D.W.,W.H. Berrettini & C.P. O'Brien. 2006. Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Addict. Biol. 11: 397-403.
248. Greenway, F.L. et al. 2009. Rational design of a combination Med.ication for the treatment of obesity. Obesity (Silver Spring) 17: 30-39.
249. Roberts, D.C. 2005. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol. Behav. 86: 18-20.
250. Di Ciano, P. & B.J. Everitt. 2004. Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur. J. Neurosci. 19: 1661-1667.
251. Paterson, N.E., W. Froestl & A. Markou. 2004. The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172: 179-186.
252. Colombo, G. et al. 2003. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl) 167: 221-224.
253. Brebner, K., A.R. Childress & D.C. Roberts. 2002. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol. 37: 478-484.
254. Ameisen, O. 2005. Complete and prolonged suppression of symptoms and consequences of alcoholdependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 40: 147-150.
255. Ameisen, O. 2008. The End of My Addiction. Farrar, Straus and Giroux. New York.
256. Addolorato, G. et al. 2006. Baclofen: a new drug for the treatment of alcohol dependence. Int. J. Clin. Pract. 60: 1003-1008.
257. Corwin, R.L. & F.H. Wojnicki. 2009. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions. Behav. Pharmacol. 20: 537-548.
258. Wojnicki, F.H., D.C. Roberts & R.L. Corwin. 2006. Effects of baclofen on operant performance for food pellets and vegetable shortening after a history of bingetype behavior in non-food deprived rats. Pharmacol. Biochem. Behav. 84: 197-206.
259. Aston-Jones, G. et al. 2009 Lateral hypothalamic orexin/hypocretin neurons: a role in rewardseeking and addiction. Brain Res. in Press. S0006- 8993(09)02096-2104 doi: 10.1016/j.brainRes.2009.09.106.
260. Harris, G.C., M. Wimmer & G. Aston-Jones. 2005. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556-559.
261. Borgland, S.L. et al. 2009. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29: 11215-11225.